MedPath

北京京丰制药(山东)有限公司

Ownership
-
Established
1994-03-14
Employees
-
Market Cap
-
Website
www.jfzysd.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

177

NMPA:177

Drug Approvals

Sulfamethoxazole,Sulfadiazine and Trimethoprim Tablets

Product Name
联磺甲氧苄啶片
Approval Number
国药准字H37020442
Approval Date
Mar 20, 2025
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H37021764
Approval Date
Mar 20, 2025
NMPA

Compound Aluminium Hydroxide Tablets

Product Name
复方氢氧化铝片
Approval Number
国药准字H37022321
Approval Date
Mar 20, 2025
NMPA

Clotrimazole Tablets

Product Name
克霉唑片
Approval Number
国药准字H37021739
Approval Date
Mar 20, 2025
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H37021763
Approval Date
Mar 20, 2025
NMPA

Vitamin U,Aluminium Hydroxide and Magnesium Trisilicate Tablets

Product Name
维U颠茄铝镁片
Approval Number
国药准字H37023450
Approval Date
Mar 20, 2025
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H37020447
Approval Date
Mar 20, 2025
NMPA

Oleanolic Acid Tablets

Product Name
齐墩果酸片
Approval Number
国药准字H37022327
Approval Date
Mar 20, 2025
NMPA

Lincomycin Hydrochloride Tablets

Product Name
盐酸林可霉素片
Approval Number
国药准字H37021745
Approval Date
Mar 20, 2025
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H37021777
Approval Date
Mar 14, 2025
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.